-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Credit Suisse Lowers eFFECTOR Therapeutics' Price Target to $8 From $10, Keeps Outperform Rating

--Credit Suisse Lowers eFFECTOR Therapeutics' Price Target to $8 From $10, Keeps Outperform Rating

MT Newswires · 01/06/2023 03:56